Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Adv Ther

Search In Journal Title:

Abbravation: Advances in Therapy

Search In Journal Abbravation:

Publisher

Springer Healthcare

Search In Publisher:

DOI

10.1016/0029-5582(64)90594-2

Search In DOI:

ISSN

1865-8652

Search In ISSN:
Search In Title Of Papers:

Advances in Clinical Cardiology

Authors: Andrew H McNeice Neil M McAleavey Ian B A Menown
Publish Date: 2014/07/30
Volume: 31, Issue: 8, Pages: 837-860
PDF Link

Abstract

Multiple potentially practicechanging cardiology trials have been presented or published over the past year In this paper we summarize and place in clinical context new data regarding management of acute coronary syndrome and STelevation myocardial infarction copeptin assessment otamixaban cangrelor prasugrel sodium nitrite inclacumab ranolazine preventive coronary intervention of nonculprit lesions immediate thrombolytic therapy versus transfer for primary intervention new coronary intervention data thrombectomy radial access pressure wire fractional flow reserve antiplatelet therapy duration and geneguidance permanent and biodegradable polymers coronary bifurcation and strategies and coronary artery bypass data off pump vs on pump Latest trials in transaortic valve implantation heart failure eplerenone aliskiren spironolactone sildenafil dopamine nesiritide omecamtiv mecarbil the algisyl left ventricular augmentation device and echoguided cardiac resynchronization atrial fibrillation edoxaban dabigatran and ablation cardiac arrest hypothermia LUCAS™ mechanical chest compression and cardiovascular prevention vitamins renal denervation for resistant hypertension renal artery stenting saxagliptin alogliptin and gastric banding are also discussedNo funding or sponsorship was received for this study or publication of this article No writing assistance was utilized in the production of this manuscript All named authors meet the ICMJE criteria for authorship for this manuscript take responsibility for the integrity of the work as a whole and have given final approval for the version to be publishedAMcN and NMcA declare no conflict of interest IM has received grants to the institution lecture/consultancy honorarium and conference sponsorship from Boston Scientific Randox Sanofi Aventis Servier Menarini Biosensors Astra Zeneca Bayer Boehringer Ingelheim Daichii Sankyo Eli Lilly Bristol Myers Squibb and Pfizer The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed

Keywords:

References

.
Search In Abstract Of Papers:
Other Papers In This Journal:
  1. Azacytidine for the treatment of myelodysplastic syndromes in the elderly
  2. Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma
  3. Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma
  4. When People with Opioid-Induced Constipation Speak: A Patient Survey
  5. Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
  6. Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
  7. Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary
  8. A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components
  9. Individualized Fludarabine-Based Regimen in Elderly Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  10. Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy
  11. Coma caused by isoniazid poisoning in a patient treated with pyridoxine and hemodialysis
  12. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment
  13. Are Dosing Adjustments Required for Colchicine in the Elderly Compared with Younger Patients?
  14. An Overview of Letrozole in Postmenopausal Women with Hormone-Responsive Breast Cancer
  15. Slovak Trial on Cardiovascular Risk Reduction Following National Guidelines with CaDUET® (The STRONG DUET Study)
  16. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy
  17. Corneal staining reductions observed after treatment with Systane® Lubricant Eye Drops
  18. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands
  19. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial
  20. Dose-Finding Study of Landiolol Hydrochloride: A Short-Acting β 1 -Blocker for Controlling Heart Rate During Coronary Computed-Tomography Angiography in Japan
  21. Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals
  22. Glial fibrillary acidic protein (GFAP) and CD34 expression in the human optic nerve and brain in methanol toxicity
  23. Urapidil, a dual-acting antihypertensive agent: Current usage considerations
Search Result: